Thyroid cancer has these types of SNV-drivers present in BRAF in 55.8% of cases, the next qualifying genes being TTN, TTN-AS1, NRAS and KMT2C all with a low incidence rate of 1.3%. This evidence concerns the gene KMT2C and thyroid gland carcinoma.